2025-08-29 01:35:04
Latest Post
Himadri Speciality Chemical Ltd Secures ISCC PLUS Certification
HCLSoftware delivers Digital Independence with AI-Powered Sovereign Collaboration Solutions for Business-Critical Infrastructure
Dr. Agarwal's Health Care Limited and Dr. Agarwal's Eye Hospital Limited announce Merger
SAMHI signs agreement to Lease for ~260-room Mid-Scale Hotel in Hyderabad's Financial District
Rail Vikas Nigam Ltd signs JV agreement with Texmaco Rail & Engineering Ltd
Stock Report
Aarey Drugs and Pharmaceuticals Q3FY22 net profit slips QoQ to Rs. 1.94 crores
Posted On : 2022-02-08 15:30:47( TIMEZONE : IST )
AAREY DRUGS & PHARMACEUTICALS LTD. has reported Standalone financial results for the period ended December 31, 2021.
Financial Results (Q3 FY2022) - QoQ Comparison
The company has reported total income of Rs. 140.3944 crores during the period ended December 31, 2021 as compared to Rs. 135.4639 crores during the period ended September 30, 2021.
The company has posted net profit / (loss) of Rs. 1.9480 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs. 2.8436 crores for the period ended September 30, 2021.
The company has reported EPS of Rs. 0.77 for the period ended December 31, 2021 as compared to Rs. 1.22 for the period ended September 30, 2021.
| Financials | Q3 FY2022 | Q2 FY2022 | % Change |
| Total Income | ₹ 140.3944 crs | ₹135.4639 crs |  3.64% |
| Net Profit | ₹1.9480 crs | ₹2.8436 crs |  -31.50% |
| EPS | ₹0.77 | ₹1.22 | -36.89% |
Financial Results (Q3 FY2022) - YoY Comparison
The company has reported total income of Rs. 140.3944 crores during the period ended December 31, 2021 as compared to Rs.97.2126 crores during the period ended December 31, 2020.
The company has posted net profit / (loss) of Rs.1.9480 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs.1.7033 crores for the period ended December 31, 2020.
The company has reported EPS of Rs.0.77 for the period ended December 31, 2021 as compared to Rs.0.73 for the period ended December 31, 2020.
| Financials | Q3 FY2022 | Q3 FY2021 | % Change |
| Total Income | ₹ 140.3944 crs | ₹97.2126 crs | 44.42% |
| Net Profit | ₹1.9480 crs | ₹1.7033 crs | 14.37% |
| EPS | ₹0.77 | ₹0.73 | 5.48% |
Financial Results (9 Months Ended FY2022) - YoY Comparison
The company has reported total income of Rs.374.0469 crores during the 9 Months period ended December 31, 2021 as compared to Rs.175.5413 crores during the 9 Months period ended December 31, 2020.
The company has posted net profit / (loss) of Rs.7.3001 crores for the 9 Months period ended December 31, 2021 as against net profit / (loss) of Rs.5.1076 crores for the 9 Months period ended December 31, 2020.
The company has reported EPS of Rs.2.88 for the 9 Months period ended December 31, 2021 as compared to Rs.2.18 for the 9 Months period ended December 31, 2020.
| Financials | 9 Months Ended FY2022 | 9 Months Ended FY2021 | % Change |
| Total Income | ₹374.0469 crs | ₹175.5413 crs | 113.08% |
| Net Profit | ₹7.3001 crs | ₹5.1076 crs | 42.93% |
| EPS | ₹2.88 | ₹2.18 | 32.11% |
Shares of AAREY DRUGS & PHARMACEUTICALS LTD. was last trading in BSE at Rs. 54.15 as compared to the previous close of Rs. 53.15. The total number of shares traded during the day was 31144 in over 737 trades.
The stock hit an intraday high of Rs. 55.85 and intraday low of 53.10. The net turnover during the day was Rs. 1689896.00.
